These returns are measured from the disclosure date forward, meaning every one of these positions was publicly visible at the time of filing and available for any reader to consider. Our review of congressional trading data has uncovered multiple purchases that achieved extraordinary gains in the time since those disclosures were made.
Two positions stand out as outliers we are still verifying. Rep. Ro Khanna bought CCG with disclosure on February 6, 2026, and Rep. Lisa McClain purchased SNDK disclosed on November 21, 2025. Both require additional review before we can finalize the performance data.
Among the verified trades, Ro Khanna bought MRNA disclosed on January 6, 2026 for a current return of 468.81 percent since disclosure. Lisa McClain's CIEN buy, disclosed August 13, 2025, has returned 333.91 percent. Tim Moore's purchase of TZA disclosed July 9, 2025 shows 316.57 percent return, while Scott H. Peters bought KSS on disclosure date May 16, 2025 with a 280.3 percent gain since.
These examples from four different House members illustrate how certain disclosed trades have substantially appreciated after becoming public. Spanning sectors from communication services and technology to healthcare and consumer cyclical, the trades underscore the importance of timely review of congressional filings. While the data suggests strong performance after disclosure in these cases, individual results will vary and broader market conditions play a significant role.
This is data analysis, not financial advice.
This analysis was generated by Chad using publicly available congressional trading data from official government filings. This is not financial advice. All data is sourced from senate.gov, clerk.house.gov, and SEC EDGAR.